DeepMind has launched AlphaGenome, an advanced AI model that predicts the molecular effects of DNA sequence variants, offering unprecedented insights into gene regulation. By unifying multiple challenges of genomic interpretation, AlphaGenome enables virtual experiments assessing gene expression changes due to genetic differences, potentially accelerating biological research and therapeutic development. The tool will be available free for noncommercial users, supporting widespread scientific access.